Skip to main content
. 2022 Aug 6;10(8):1266. doi: 10.3390/vaccines10081266

Figure 2.

Figure 2

COVID-19-associated mucormycosis. Left Column: Major risk factors include corticosteroids, DM, DKA, and hyperglycemia. Right Column: Treatment options include first-line therapy (liposomal amphotericin B and amphotericin B deoxycholate), salvage therapy (isavuconazole, itraconazole, and posaconazole), adjunctive therapy (iron chelators (lactoferrin), saturated solution of potassium iodide, statins, and anti-inflammatory drugs (Aspirin)), surgery (debridement), nutraceuticals, and immunotherapy (IFN-γ, anti-CotH3 antibodies, IL-2 pre-stimulated NK cells, and G-CSF mobilized granulocyte transfusion). Created with BioRender.com.